牛叉诊股

[{"date":"2026.04.30","stock":"0.04","trade":"0.52","ind":"-0.09"},{"date":"2026.04.29","stock":"-0.13","trade":"0.65","ind":"1.96"},{"date":"2026.04.28","stock":"0.99","trade":"-0.61","ind":"-1.10"},{"date":"2026.04.27","stock":"2.21","trade":"0.54","ind":"0.37"},{"date":"2026.04.24","stock":"1.73","trade":"-0.33","ind":"-0.69"},{"date":"2026.04.23","stock":"-0.56","trade":"-1.30","ind":"-0.88"},{"date":"2026.04.22","stock":"1.46","trade":"0.43","ind":"1.30"},{"date":"2026.04.21","stock":"0.86","trade":"-0.98","ind":"0.10"},{"date":"2026.04.20","stock":"-6.00","trade":"-0.37","ind":"0.55"},{"date":"2026.04.17","stock":"-2.57","trade":"-1.46","ind":"0.60"},{"date":"2026.04.16","stock":"0.17","trade":"-0.14","ind":"2.05"},{"date":"2026.04.15","stock":"2.42","trade":"2.24","ind":"-0.97"},{"date":"2026.04.14","stock":"1.27","trade":"0.68","ind":"1.61"},{"date":"2026.04.13","stock":"-2.60","trade":"-0.85","ind":"0.69"},{"date":"2026.04.10","stock":"0.80","trade":"0.52","ind":"2.24"},{"date":"2026.04.09","stock":"-1.06","trade":"-2.18","ind":"-0.33"},{"date":"2026.04.08","stock":"2.16","trade":"1.06","ind":"4.79"},{"date":"2026.04.07","stock":"-1.94","trade":"0.46","ind":"0.36"},{"date":"2026.04.03","stock":"-1.22","trade":"-2.72","ind":"-0.99"},{"date":"2026.04.02","stock":"-0.61","trade":"1.12","ind":"-1.60"},{"date":"2026.04.01","stock":"3.13","trade":"4.62","ind":"1.70"}]

恩华药业,深证成指,化学制药指数

压力支撑

该股压力位为22.43元，支撑位为22.25元。

[{"text":"\u538b\u529b\u4f4d","value":"22.43","date":1777478400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"22.25","date":1777478400,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.2资金面打败了58%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：04月30日 20:30

机构今日流向(万元)	-879.60	机构5日流向(万元)	-3658.00
机构10日流向(万元)	-14998.67	机构20日流向(万元)	-26119.73

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量增加5427.27万股，其中基金净减仓57家，主力净增仓22家，请投资者中长期谨慎为宜。

截止2025-12-31，共348家主力机构（基金343家，一般法人2家，社保基金3家），持仓量总计47500.49万股，占流通A股53.74%
其中，基金持仓与2025-06-30相比：
增仓：42家，增持 1021.55万股
减仓：99家，减持 852.70万股
新出现在主力名单中：187家，持有10689.48万股
从主力名单中消失：165家，原持有5431.06万股

消息面诊股

诊断结果：6.6消息面打败了59%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	年度股东大会	2026-04-18
利好	分红转增	10派4元(含税)	2026-04-18
一般消息	高管变动	取消监事会	2025-12-19
一般消息	分红转增	不分配不转增	2025-07-30

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：5.3行业面打败了70%的股票化学制药行业最新资金流向

近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑输大盘。

[{"date":"2026.04.30","price":"-0.09","value":"0.52"},{"date":"2026.04.29","price":"1.96","value":"0.65"},{"date":"2026.04.28","price":"-1.10","value":"-0.61"},{"date":"2026.04.27","price":"0.37","value":"0.54"},{"date":"2026.04.24","price":"-0.69","value":"-0.33"},{"date":"2026.04.23","price":"-0.88","value":"-1.30"},{"date":"2026.04.22","price":"1.30","value":"0.43"},{"date":"2026.04.21","price":"0.10","value":"-0.98"},{"date":"2026.04.20","price":"0.55","value":"-0.37"},{"date":"2026.04.17","price":"0.60","value":"-1.46"},{"date":"2026.04.16","price":"2.05","value":"-0.14"},{"date":"2026.04.15","price":"-0.97","value":"2.24"},{"date":"2026.04.14","price":"1.61","value":"0.68"},{"date":"2026.04.13","price":"0.69","value":"-0.85"},{"date":"2026.04.10","price":"2.24","value":"0.52"},{"date":"2026.04.09","price":"-0.33","value":"-2.18"},{"date":"2026.04.08","price":"4.79","value":"1.06"},{"date":"2026.04.07","price":"0.36","value":"0.46"},{"date":"2026.04.03","price":"-0.99","value":"-2.72"},{"date":"2026.04.02","price":"-1.60","value":"1.12"},{"date":"2026.04.01","price":"1.70","value":"4.62"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	美诺华	56.97%	12.44%	6.1分
2	多瑞医药	32.69%	11.27%	5.7分
3	宏源药业	28.19%	26.72%	6.7分
4	通化金马	24.41%	7.45%	5.9分
5	纳微科技	24.17%	-2.10%	5.5分
6	博瑞医药	23.87%	3.14%	4.6分
7	莱美药业	23.84%	2.90%	4.8分
8	共同药业	23.48%	23.03%	6.2分
9	仟源医药	14.12%	13.64%	6.5分
10	贝达药业	13.23%	4.09%	6.4分
11	南新制药	12.16%	23.28%	4.9分
12	一品红	11.45%	19.97%	6.2分
13	金石亚药	11.39%	10.32%	5.8分
14	尔康制药	9.55%	2.11%	5.4分
15	罗欣药业	9.29%	-1.78%	6.5分
16	司太立	8.44%	14.18%	5.1分
17	*ST惠程	7.29%	-2.06%	5.0分
18	金城医药	7.11%	-3.36%	5.5分
19	-	6.12%	3.12%	分
20	益方生物	5.53%	2.96%	5.2分
21	海正药业	5.11%	0.71%	5.4分
22	-	5.07%	-0.59%	分
23	ST天圣	5.04%	9.27%	5.8分
24	常山药业	4.66%	3.14%	4.2分
25	*ST三圣	4.47%	-2.30%	5.1分
26	本立科技	4.15%	5.55%	6.2分
27	溢多利	3.75%	13.26%	5.9分
28	-	3.68%	-0.91%	分
29	-	3.56%	-1.37%	分
30	-	3.54%	1.79%	分
31	民生健康	3.29%	4.83%	5.6分
32	赛托生物	3.00%	12.17%	6.7分
33	翰宇药业	2.93%	-5.94%	5.0分
34	悦康药业	2.62%	-1.21%	4.2分
35	圣诺生物	2.27%	-0.19%	5.1分
36	兴齐眼药	1.86%	1.82%	5.2分
37	威尔药业	1.84%	5.52%	5.3分
38	微芯生物	1.72%	3.47%	5.3分
39	汇宇制药	1.47%	4.17%	5.2分
40	新和成	1.34%	0.17%	5.1分
41	科源制药	1.29%	-3.83%	5.3分
42	海思科	1.19%	3.89%	6.7分
43	德展健康	1.11%	8.01%	4.8分
44	富祥药业	1.05%	7.33%	5.4分
45	-	0.90%	3.40%	分
46	奥赛康	0.89%	6.14%	6.5分
47	泰恩康	0.84%	0.28%	4.7分
48	金陵药业	0.82%	-1.07%	5.2分
49	普洛药业	0.55%	0.16%	5.5分
50	泽璟制药	-0.10%	6.12%	5.5分
51	哈药股份	-0.28%	-7.73%	4.5分
52	前沿生物	-0.33%	10.22%	5.0分
53	广济药业	-0.67%	12.65%	5.9分
54	誉衡药业	-0.85%	-3.56%	5.1分
55	ST人福	-1.00%	2.00%	5.4分
56	津药药业	-1.04%	-15.43%	4.8分
57	广生堂	-1.45%	-1.76%	5.0分
58	河化股份	-1.55%	7.37%	5.8分
59	键凯科技	-1.57%	-7.37%	4.6分
60	首药控股	-1.78%	5.80%	4.7分
61	华海药业	-1.81%	0.93%	5.4分
62	ST诺泰	-2.04%	1.64%	4.3分
63	ST复华	-2.12%	7.94%	4.8分
64	-	-2.34%	1.68%	分
65	福安药业	-2.36%	0.73%	5.0分
66	海创药业	-2.37%	-6.64%	4.1分
67	复旦张江	-2.54%	4.27%	4.5分
68	赛分科技	-2.55%	-3.52%	5.4分
69	西点药业	-2.87%	8.22%	6.2分
70	恩华药业	-2.94%	4.91%	5.2分
71	东亚药业	-3.10%	2.55%	5.3分
72	永安药业	-3.18%	4.10%	5.2分
73	卫信康	-3.20%	3.92%	5.5分
74	海欣股份	-3.36%	0.24%	5.6分
75	诚意药业	-3.66%	-0.42%	5.1分
76	奥翔药业	-3.72%	-0.91%	4.6分
77	汉商集团	-3.73%	2.93%	5.3分
78	丰原药业	-3.87%	2.06%	5.5分
79	迪哲医药	-4.01%	-0.21%	4.4分
80	鲁抗医药	-4.24%	-0.61%	4.6分
81	-	-4.30%	-2.02%	分
82	科伦药业	-4.48%	4.13%	5.2分
83	华仁药业	-4.55%	3.28%	5.7分
84	同和药业	-4.87%	-0.51%	5.5分
85	健康元	-4.87%	0.28%	5.0分
86	仙琚制药	-4.88%	-2.12%	4.8分
87	华润双鹤	-5.00%	-1.11%	5.0分
88	天新药业	-5.04%	-2.01%	4.4分
89	昂利康	-5.16%	-15.61%	4.3分
90	新天地	-5.63%	1.33%	4.8分
91	宣泰医药	-5.68%	1.64%	4.9分
92	易明医药	-5.84%	-5.06%	5.4分
93	莎普爱思	-5.87%	5.81%	5.0分
94	海普瑞	-5.89%	-1.00%	5.2分
95	百济神州	-6.04%	0.20%	4.5分
96	华纳药厂	-6.26%	3.66%	4.6分
97	艾力斯	-6.44%	-3.91%	4.3分
98	丽珠集团	-6.45%	-2.71%	4.8分
99	拓新药业	-6.53%	0.41%	3.9分
100	哈三联	-6.55%	8.44%	5.2分
101	恒瑞医药	-6.67%	-4.47%	4.8分
102	北大医药	-6.71%	-3.01%	4.2分
103	凯因科技	-6.88%	-4.77%	3.9分
104	亨迪药业	-6.89%	0.44%	5.2分
105	神奇制药	-6.96%	1.91%	5.8分
106	新华制药	-7.00%	-1.95%	4.6分
107	盟科药业	-7.10%	2.21%	4.4分
108	向日葵	-7.18%	3.19%	4.6分
109	小方制药	-7.24%	-5.17%	4.1分
110	华北制药	-7.30%	-2.07%	4.4分
111	国邦医药	-7.54%	-0.29%	5.2分
112	华邦健康	-7.62%	-8.13%	4.4分
113	健友股份	-7.83%	-2.03%	4.6分
114	复星医药	-8.05%	-2.66%	4.4分
115	华东医药	-8.23%	-2.17%	5.1分
116	海森药业	-8.60%	-8.53%	4.5分
117	富士莱	-8.62%	5.26%	5.1分
118	灵康药业	-8.76%	5.16%	5.1分
119	川宁生物	-8.82%	3.51%	4.8分
120	山河药辅	-8.85%	2.17%	5.2分
121	花园生物	-9.06%	-1.51%	4.1分
122	北陆药业	-9.46%	-0.63%	4.8分
123	海辰药业	-9.64%	0.74%	5.2分
124	华特达因	-9.81%	-3.88%	4.8分
125	天宇股份	-9.83%	-3.92%	4.9分
126	ST景峰	-9.87%	0.71%	4.6分
127	中关村	-10.21%	-4.81%	5.2分
128	浙江医药	-10.41%	-0.75%	5.0分
129	东北制药	-10.53%	-2.95%	4.5分
130	立方制药	-10.72%	-3.48%	5.5分
131	国药现代	-10.79%	-1.84%	5.0分
132	吉贝尔	-10.83%	-5.15%	4.1分
133	东诚药业	-10.84%	-4.56%	4.5分
134	海南海药	-10.87%	-2.53%	4.2分
135	九典制药	-11.26%	-5.86%	4.2分
136	亚虹医药	-11.43%	-1.53%	4.1分
137	千红制药	-11.62%	-6.17%	4.2分
138	新诺威	-11.84%	-2.22%	4.4分
139	上海谊众	-11.86%	5.75%	4.4分
140	辰欣药业	-12.00%	0.39%	4.2分
141	苑东生物	-12.03%	-0.19%	5.1分
142	亚太药业	-12.60%	-1.61%	4.4分
143	京新药业	-12.65%	-2.05%	4.9分
144	海翔药业	-12.79%	-8.51%	5.2分
145	百利天恒	-12.83%	-5.14%	3.9分
146	康芝药业	-13.25%	4.37%	4.8分
147	-	-13.41%	-6.69%	分
148	舒泰神	-15.25%	-4.26%	4.1分
149	力生制药	-15.27%	-8.74%	4.7分
150	福元医药	-15.58%	-6.79%	4.8分
151	双鹭药业	-16.47%	-9.61%	3.9分
152	亿帆医药	-16.50%	-4.85%	4.5分
153	ST能特	-18.21%	-5.69%	4.6分
154	信立泰	-22.35%	-8.36%	5.1分
155	润都股份	-23.32%	7.31%	5.8分
156	必贝特	-24.26%	-8.96%	4.7分
157	联环药业	-24.82%	12.16%	6.2分
158	奥锐特	-27.31%	-13.84%	4.3分
159	*ST赛隆	-28.14%	-22.65%	4.5分

<上一页 1 2 3 4 5...27 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：6.2基本面打败了62%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：中（90分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 23/219 ， 31/219。

[{"date":"2026-03-31","value":"3.86","vol":"0.42"},{"date":"2025-12-31","value":"13.77","vol":"-1.85"},{"date":"2025-09-30","value":"14.36","vol":"1.53"},{"date":"2025-06-30","value":"9.36","vol":"1.23"},{"date":"2025-03-31","value":"4.03","vol":"-0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	3.86	13.77	14.36	9.36	4.03
行业(%)	0.42	-1.85	1.53	1.23	-0.13

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"70.97","vol":"50.73"},{"date":"2025-12-31","value":"72.13","vol":"49.96"},{"date":"2025-09-30","value":"76.02","vol":"49.60"},{"date":"2025-06-30","value":"75.24","vol":"49.57"},{"date":"2025-03-31","value":"74.69","vol":"49.05"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	70.97	72.13	76.02	75.24	74.69
行业(%)	50.73	49.96	49.60	49.57	49.05

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 55/219 ， 64/219。

[{"date":"2026-03-31","value":"6.58","vol":"24.40"},{"date":"2025-12-31","value":"3.75","vol":"38.58"},{"date":"2025-09-30","value":"7.85","vol":"141.64"},{"date":"2025-06-30","value":"8.93","vol":"78.57"},{"date":"2025-03-31","value":"11.29","vol":"0.03"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	6.58	3.75	7.85	8.93	11.29
行业(%)	24.40	38.58	141.64	78.57	0.03

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"5.56","vol":"40.77"},{"date":"2025-12-31","value":"-7.54","vol":"-24.51"},{"date":"2025-09-30","value":"8.42","vol":"-2.93"},{"date":"2025-06-30","value":"11.38","vol":"58.23"},{"date":"2025-03-31","value":"13.35","vol":"-10.52"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	5.56	-7.54	8.42	11.38	13.35
行业(%)	40.77	-24.51	-2.93	58.23	-10.52

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 14/219 ， 53/219。

[{"date":"2026-03-31","value":"0.17","vol":"0.10"},{"date":"2025-12-31","value":"0.67","vol":"0.41"},{"date":"2025-09-30","value":"0.51","vol":"0.31"},{"date":"2025-06-30","value":"0.35","vol":"0.21"},{"date":"2025-03-31","value":"0.17","vol":"0.10"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.17	0.67	0.51	0.35	0.17
行业(次)	0.10	0.41	0.31	0.21	0.10

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.64","vol":"0.65"},{"date":"2025-12-31","value":"2.32","vol":"2.55"},{"date":"2025-09-30","value":"1.39","vol":"1.93"},{"date":"2025-06-30","value":"1.06","vol":"1.29"},{"date":"2025-03-31","value":"0.58","vol":"0.65"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.64	2.32	1.39	1.06	0.58
行业(次)	0.65	2.55	1.93	1.29	0.65

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"9.80","vol":"-2.86"},{"date":"2025-12-31","value":"11.61","vol":"14.76"},{"date":"2025-09-30","value":"28.50","vol":"4.27"},{"date":"2025-06-30","value":"11.71","vol":"2.95"},{"date":"2025-03-31","value":"21.13","vol":"-26.34"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	9.80	11.61	28.50	11.71	21.13
行业	-2.86	14.76	4.27	2.95	-26.34

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.64","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.14","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	1.64	-	1.14	-
行业	0.00	1.60	0.00	1.71	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 125/219 ， 125/219。

[{"date":"2026-03-31","value":"5.69","vol":"3.58"},{"date":"2025-12-31","value":"5.92","vol":"3.33"},{"date":"2025-09-30","value":"7.29","vol":"3.48"},{"date":"2025-06-30","value":"6.05","vol":"3.66"},{"date":"2025-03-31","value":"5.50","vol":"3.57"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	5.69	5.92	7.29	6.05	5.50
行业	3.58	3.33	3.48	3.66	3.57

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"5.00","vol":"2.94"},{"date":"2025-12-31","value":"5.13","vol":"2.71"},{"date":"2025-09-30","value":"6.24","vol":"2.73"},{"date":"2025-06-30","value":"5.27","vol":"2.88"},{"date":"2025-03-31","value":"4.88","vol":"2.80"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	5.00	5.13	6.24	5.27	4.88
行业	2.94	2.71	2.73	2.88	2.80

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 120/219 ， 122/219。

[{"date":"2026-03-31","value":"13.45","vol":"33.32"},{"date":"2025-12-31","value":"12.96","vol":"34.57"},{"date":"2025-09-30","value":"11.06","vol":"34.05"},{"date":"2025-06-30","value":"13.01","vol":"34.11"},{"date":"2025-03-31","value":"14.39","vol":"34.08"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	13.45	12.96	11.06	13.01	14.39
行业(%)	33.32	34.57	34.05	34.11	34.08

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.15","vol":"9.89"},{"date":"2025-12-31","value":"0.15","vol":"1.77"},{"date":"2025-09-30","value":"0.12","vol":"1.19"},{"date":"2025-06-30","value":"0.15","vol":"0.87"},{"date":"2025-03-31","value":"0.17","vol":"1.44"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.15	0.15	0.12	0.15	0.17
行业(%)	9.89	1.77	1.19	0.87	1.44

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
华西证券	2026-04-23	增持
华泰证券	2026-04-22	买入	买入

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"9.01","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"10.37","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"11.44","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"10.57","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"13.08","blueLineValue":"1.29","type":"YC"}]

[恩华药业]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]